GOVX: יתרות מזומנים למניה GeoVax Corp

The cash per share value for GeoVax Labs, Inc. (GOVX) demonstrates current liquidity, with the final metric standing at 3.99. This trend is supported by a broad portfolio of cancer and viral vaccines, as well as the implementation of automated laboratory systems. Asset stability is ensured by an academic staff of virologists whose motivation is tied to grants and the success of clinical trials.
פילוחים אנליטיים של חברת GeoVax Labs, Inc.

Cash per share determines the portion of liquid assets attributable to a single security. This metric allows for an assessment of real cash capital support, excluding liabilities. By analyzing cash per share over time, an investor determines the issuer's financial strength reserve. For GeoVax Labs, Inc. (GOVX), this resource is critical amid fierce competition for grants. Liquidity ensures the company's survival in the high-risk vaccine development race.